Similar articles

• Intraventricular administration of amikacin for complicated Gram-negative meningitis and ventriculitis.

  Wirt TC, McGee ZA, Oldfield EH, Meacham WF. Wirt TC, et al. J Neurosurg. 1979 Jan;50(1):95-9. doi: 10.3171/jns.1979.50.1.0095. J Neurosurg. 1979. PMID: 363982
• Intrathecal amikacin administration. Use in the treatment of gentamicin-resistant Klebsiella pneumoniae meningitis.

  Hamory B, Ignatiadis P, Sande MA. Hamory B, et al. JAMA. 1976 Oct 25;236(17):1973-4. doi: 10.1001/jama.236.17.1973. JAMA. 1976. PMID: 787564 No abstract available.
• Amikacin therapy of gram-negative bacteremia and meningitis. Treatment in diseases due to multiple resistant bacilli.

  Sklaver AR, Greenman RL, Hoffman TA. Sklaver AR, et al. Arch Intern Med. 1978 May;138(5):713-6. Arch Intern Med. 1978. PMID: 348135
• Klebsiella meningitis treated with intrathecal amikacin.

  Block CS, Cassel R, Koornhof HJ, Robinson RG, Lewer-Allen CM. Block CS, et al. Lancet. 1977 Jun 25;1(8026):1371-2. doi: 10.1016/s0140-6736(77)92593-4. Lancet. 1977. PMID: 69095 No abstract available.
• Successful treatment of ceftazidime-resistant Klebsiella pneumoniae ventriculitis with intravenous meropenem and intraventricular polymyxin B: case report and review.

  Segal-Maurer S, Mariano N, Qavi A, Urban C, Rahal JJ Jr. Segal-Maurer S, et al. Clin Infect Dis. 1999 May;28(5):1134-8. doi: 10.1086/514754. Clin Infect Dis. 1999. PMID: 10452648 Review.